Chai-Qin-Cheng-Qi Decoction and Carbachol Improve Intestinal Motility by Regulating Protein Kinase C-Mediated Ca(2+) Release in Colonic Smooth Muscle Cells in Rats with Acute Necrotising Pancreatitis.

Chai-Qin-Cheng-Qi Decoction and Carbachol Improve Intestinal Motility by Regulating Protein Kinase C-Mediated Ca(2+) Release in Colonic Smooth Muscle Cells in Rats with Acute Necrotising Pancreatitis.
复制标题

柴芩承气汤和卡巴胆碱通过调节蛋白激酶C介导的急性坏死性胰腺炎大鼠结肠平滑肌细胞Ca2+释放来改善肠蠕动

DOI:
10.1155/2017/5864945
复制
发表时间:
2017
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
通讯作者:
Xia Q
Xia Q
中科院分区:
其他
文献类型:
--
作者:
Zhang CL;Lin ZQ;Luo RJ;Zhang XX;Guo J;Wu W;Shi N;Deng LH;Chen WW;Zhang XY;Bharucha S;Huang W;Sutton R;Windsor JA;Xue P;Xia Q

文献摘要

相似文献

柴芩承气汤(CQCQD)改善急性胰腺炎(AP)患者肠道蠕动,但其作用机制尚不清楚。我们研究了CQCQD和促动力学剂carbachol对l -精氨酸诱导的大鼠坏死性AP模型结肠平滑肌细胞(SMCs)的影响。治疗组在AP诱导24 h后灌胃CQCQD (20 g/kg, 2 h × 3剂量)或腹腔灌胃carbachol (60 μg/kg), CQCQD和carbachol均可降低胰腺和结肠组织病理的严重程度(均P < 0.05)。CQCQD和carbachol均可降低血清肠脂肪酸结合蛋白、血管活性肠肽和P物质,并增加运动性水平。CQCQD上调SMC磷脂酶c -β1 (PLC-β1) mRNA和PLC蛋白(均P < 0.05),上调蛋白激酶c -α (PKC-α) mRNA和PKC蛋白,下调腺苷酸环化酶(AC) mRNA和蛋白(均P < 0.05)。两种处理均未显著改变l -精氨酸诱导的PKC-β1和PKC-ε mRNA的减少。两种处理均显著提高了SMC细胞内钙浓度[Ca2+]i的荧光强度(3563.5和3046.9比1086.9,P均< 0.01)。这些数据表明,CQCQD和carbachol通过上调PLC、PKC和下调AC来增加结肠SMCs中的[Ca2+]i,从而改善AP的肠道运动。
Chai-Qin-Cheng-Qi decoction (CQCQD) improves intestinal motility in acute pancreatitis (AP), but the mechanism(s) require elucidation. We investigated the effects of CQCQD and carbachol, a prokinetic agent, on colonic smooth muscle cells (SMCs) in L-arginine-induced necrotising AP model in rats. In treatment groups, intragastric CQCQD (20 g/kg, 2 hourly × 3 doses) or intraperitoneal carbachol (60 μg/kg) was given 24 hours after induction of AP. Both CQCQD and carbachol decreased the severity of pancreatic and colonic histopathology (all P < 0.05). Both CQCQD and carbachol reduced serum intestinal fatty acid binding protein, vasoactive intestinal peptide, and substance P and increased motility levels. CQCQD upregulated SMC phospholipase C-beta 1 (PLC-β1) mRNA and PLC protein (both P < 0.05), while both treatments upregulated protein kinase C-alpha (PKC-α) mRNA and PKC protein and downregulated adenylate cyclase (AC) mRNA and protein compared with no treatment (all P < 0.05). Neither treatment significantly altered L-arginine-induced PKC-β1 and PKC-ε mRNA reduction. Both treatments significantly increased fluorescence intensity of SMC intracellular calcium concentration [Ca2+]i (3563.5 and 3046.9 versus 1086.9, both P < 0.01). These data suggest CQCQD and carbachol improve intestinal motility in AP by increasing [Ca2+]i in colonic SMCs via upregulating PLC, PKC and downregulating AC.